Table 3.
Unadjusted | Adjusted | |||||||
---|---|---|---|---|---|---|---|---|
Heterosexuals | Bisexuals | OR | 95% CI | p-Value | AOR | 95% CI | p-Value | |
Smoking Abstinence (7 day pp, RO) | ||||||||
3 months (N = 1939) | 285 (16.4%) | 35 (17.5%) | 1.08 | 0.74–1.59 | .69 | 1.19 | 0.79–1.79 | .41 |
12 months (N = 1448) | 481 (37.3%) | 63 (39.9%) | 1.12 | 0.80–1.56 | .53 | 1.08 | 0.75–1.55 | .68 |
24 months (N = 1514) | 656 (48.8%) | 86 (50.3%) | 1.06 | 0.77–1.46 | .72 | 1.03 | 0.74–1.45 | .86 |
Vaping Abstinence (7 day pp, RO) | ||||||||
3 months (N = 1936) | 180 (10.4%) | 38 (19.1%) | 2.04 | 1.39–3.00 | <0.001 | 1.56 | 1.03–2.37 | .04 |
12 months (N = 1444) | 309 (24.0%) | 38 (23.9%) | 0.99 | 0.67–1.46 | .97 | 0.74 | 0.49–1.11 | .15 |
24 months (N = 1516) | 440 (32.7%) | 59 (34.5%) | 1.08 | 0.78–1.52 | .64 | 0.85 | 0.60–1.23 | .39 |
Dual Use Status (RO) | ||||||||
3 months (N = 1936) | 1284 (73.9%) | 129 (64.8%) | 0.65 | 0.48–0.89 | <.01 | 0.70 | 0.50–0.97 | .03 |
12 months (N = 1442) | 586 (45.6%) | 70 (44.3%) | 0.95 | 0.68–1.32 | .75 | 1.16 | 0.81–1.66 | .42 |
24 months (N = 1514) | 434 (32.3%) | 57 (33.3%) | 1.05 | 0.75–1.47 | .79 | 1.23 | 0.86–1.77 | .25 |
Smoking Abstinence (7 day pp, ITT) | ||||||||
3 months (N = 2706) | 285 (11.8%) | 35 (11.9%) | 1.01 | 0.69–1.47 | .96 | 1.09 | 0.73–1.62 | .68 |
12 months (N = 2706) | 481 (19.9%) | 63 (21.4%) | 1.10 | 0.81–1.47 | .55 | 1.03 | 0.75–1.42 | .84 |
24 months (N = 2706) | 656 (27.2%) | 86 (29.3%) | 1.11 | 0.85–1.45 | .46 | 1.07 | 0.80–1.42 | .67 |
Abbreviations: 7 day pp=7-day point-prevalence; RO=responders only; AOR=adjusted odd ratio for study condition, sex, age, and income; CI=confidence interval; ITT=Intent to treat